Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Annual Meeting

"Normally one would expect a company to reduce that maximum in the same ratio. But the BoD and thus PTSC is not doing the "normal" thing. Please read my initial posts. If someone can prove me wrong let me know."

Not true in my experience. Why don't you prove your point by giving examples of reverse splits where the authorized was reduced also. I've never seen that.

Share
New Message
Please login to post a reply